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Medical conditions in children with Down syndrome: a
literature review
Background: Children with Down syndrome experience an array of medical conditions
and health care problems. Although there have been vast improvements in the medical
management of these conditions, they still significantly impact on quality of life for
families and children with Down syndrome. However, despite the magnitude of this
problem limited literature has described the overall health status of children with Down
syndrome.
Aim: The purpose of this review was to describe the medical conditions commonly
experienced by children with Down syndrome and to consider the clinical implications of
this knowledge.
Methods: Databases Medline, CINHAL and PsychiNFO were electronically searched to
identify relevant articles from 1990 to 2009. Inclusion criteria were children aged 18
years or younger with a diagnosis of Down syndrome, who had one or more medical comorbidity. Articles were excluded at the title or abstract level if they were not peer
reviewed, English articles, or did not meet the inclusion criteria. A narrative review of
this research was possible.
Results: Common medical conditions experienced by children with Down syndrome
include: cardiac and gastrointestinal disorders, musculoskeletal disorders, respiratory
problems, eye and visual defeCts, ear and hearing impairments, frequent episodic illnesses
and infections, and a greater risk of leukaemia and thyroid conditions. Prevalence
estimates for these conditions varied depending on the diagnostic criteria or study
methodologies.
Conclusion: Knowledge of the high levels of co-morbidities experienced by children
with Down syndrome will lead to the development of more effective interventions for
teachers and health care professionals, and also assist in the provision and resource
allocation of disability services.

Author: Kelly Thomas
Supervisors: Dr Sonya Girdler,
Dr Helen Leonard and Ms Jenny Bourke
Submission date: August, 2009
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Medical conditions in children with Down syndrome: a
literature review
Introduction
~---,

Down syndrome is a chromosomal birth disorder and the single most common cause of
intellectual disability in Western Australia [1]. The worldwide prevalence of Down
syndrome varies and may be determined by accessibility to prenatal screening [2], sociocultural attitudes, religious beliefs and political legislation regarding termination of
pregnancy [3]. In Western Australia since 1980, the number of children born with Down
syndrome has remained relatively stable at approximately 1 per 1000 births, however the
overall cases of Down syndrome conceptions (live births, still births and terminations of
pregnancy) has more than doubled, from 1.2 per 1000 conceptions in 1980-84, to 2.6 per
1000 in 2006 [4]. This change in the epidemiology of Down syndrome has been largely
the result of increasing maternal age [5] and the widespread utilisation of early prenatal
screening [6].
It is well documented that Down syndrome is strongly correlated with maternal age [7].

Due to the changing roles of women in westernised societies, major socio-demographic
shifts have resulted in increasing maternal age. Within the Australian context, women's
participation in the workforce has increased from 40% in 1979 to 55% in 2006 [8, 9] and
their educational attainment is now similar to that of men [10]. As a result, the
postponement of childbirth has contributed to the overall increase in Down syndrome
conceptions [4].
The large increase in the reporting of Down syndrome conceptions is attributed to the
accessibility and utilisation of antenatal screening programs. In Australia, since 1999, the
rate of women's participation in antenatal screening programs has increased 2.5 fold to
44% [11] and the proportion of Down syndrome cases diagnosed prenatally for women
under 35 has increased from 3% to 60% [12]. As a result, foetuses which would usually
have spontaneously miscarried, are now being detected, contributing to an increase in the
reporting of Down syndrome conceptions [12, 13]. However, a corresponding increase in
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terminations of Down syndrome pregnancies has resulted in a relatively stable prevalence
of Down syndrome live births [14]. Rates of terminations are however influenced by
countries' differing legislation regarding termination of pregnancy and their societies
socio-cultural beliefs [3].
Developed countries have seen dramatic improvements in infant survival and overall life
expectancy for people with Down syndrome. In Australia over the past 40 years, the
average life expectancy of people with Down syndrome has increased from 18 to 60
years of age [14]. Of particular significance is the improvement in infant survival
whereby 91% of infants are expected to survive to one year, and 85% to ten years [15].
These rates are comparable to other developed countries [16, 17]. Internationally, there
are ethnic disparities associated with infant survival with American research reporting
black maternal race having a seven -fold increase in the risk of infant mortality, but only
among infants without cardiac defects [16]. Within Australia, survival of Aboriginal
children with Down syndrome is also significantly reduced compared to non-Aboriginal
children [15].

Several factors have contributed to improvements in the survival rates for children with
Down syndrome. The most important of these has been surgical advances in the
management of congenital heart disease [17]. In addition, improved accessibility to
antibiotics and vaccinations have contributed to a decline in morbidity and improved life
expectancy of people with Down syndrome [14]. Changes in community and health
professionals' attitudes have also influenced health care accessibility and survival [14],
whereby people with Down syndrome are now afforded a higher degree of equality in the
health care system [18]. However, ethical debates still persist in relation to implementing
policies of equality when accounting for limited resources [18].

Children with Down syndrome experience an array of medical conditions and health care
problems which have been widely documented.

Although there have been vast

improvements in the medical management of these conditions leading to increased rates
of infant and child survival [13], these comorbidities still impact on quality of life for
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families and children with Down syndrome. However, despite the magnitude of this
problem limited literature has described the overall health status of children with Down
syndrome. Therefore the objective of this narrative literature review is to describe the
medical conditions commonly experienced by children with Down syndrome and to
consider the clinical implications of this knowledge.

Methods
Databases Medline, CINHAL and PsychiNFO were electronically searched to identify
relevant articles. The data bases were searched from 1990 to 2009 so as to only include
the most recent literature in this review. The databases were also restricted to include
only peer reviewed published articles, English articles and those which included children
younger than 18 years. The main search terms were: Down syndrome, medical
conditions, cardiac, gastrointestinal, respiratory, ophthalmic, ear, hearing, thyroid,
diabetes, musculoskeletal, cancer and leukaemia. These terms were truncated and
exploded to include all relevant disorders and terminology under these headings. Search
terms were also adjusted to match the specific database being searched. Articles were
included if they focused on children aged 18 years or younger with a diagnosis of Down
syndrome, and one or more medical co-morbidities.
The intention of this review was to provide an overview of the most current and relevant
literature and therefore focused on more recent literature discerning important results.
Articles were excluded at the title or abstract level if they did not meet the inclusion
criteria. Conference proceedings were not searched. Formal quality appraisal was not
performed however within epidemiological studies this is not commonly undertaken [19].
Furthermore, no meta-analysis was performed in this literature review due to significant
differences between cohorts (population, school or hospital based cohorts) and the
different methods of collecting prevalence estimates.
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Results
A review of the literature supports the conclusion that children born with Down
syndrome commonly experience a variety of additional birth defects and other health
related problems. Medical conditions commonly associated with Down syndrome
include; cardiac and gastrointestinal disorders, musculoskeletal problems, respiratory
problems, eye and visual defects, ear and hearing defects, and frequent episodic illnesses
and infections. In addition, research has also highlighted the increased risk that children
with Down syndrome have of developing leukaemia and thyroid conditions.
Congenital heart defects

Cardiac defects are reported to be the most common occurring birth defect associated
with Down syndrome, with prevalence estimates ranging between 40-50% [16, 20]. The
most frequently occurring congenital heart defects include atrioventricular septal defect
(AVSD), atrial septal defect (ASD), ventricular septal defect (VSD), tetralogy of Fallot
[21], and patent ductus arteriosus (PDA) [22]. Congenital cardiac defects have been a
major cause of mortality for children with Down syndrome [2, 17]. Even with advances
in corrective surgery for cardiac malformations, which have resulted in significant
improvements in survival and quality of life among children with Down syndrome,
cardiac disease still remains a major predictor of mortality [15].

Gastrointestinal disorders

Children with Down syndrome experience a higher prevalence of gastrointestinal
disorders than their peers [23, 24] with congenital gastrointestinal defects occurring in
approximately 6. 7% of infants with Down syndrome [25]. Commonly experienced
gastrointestinal disorders include duodenal atresia, congenital malformations of the colon
and rectum, Hirschsprung disease [23], gastro-oesophageal reflux [26] and coeliac
disease [27, 28]. In addition, constipation, although not a serious condition, is relatively
common among these children and often involves prolonged management, placing
increased demands on family and carers [29].
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Although there was considerable literature pertaining to prevalence and screening for
coeliac disease, [30-33], research on serious congenital gastrointestinal defects is less
comprehensive. This could be attributed to increases in corrective surgery undertaken in
infancy resulting in fewer cases of gastrointestinal disorders present in childhood.
Hirschsprung's disease however is an exception with a higher representation within the
literature. The long term outcomes of Hirschsprung' s disease have been researched and
indicate that incontinence or soiling is frequent among children with Down syndrome and
Hirschsprung's disease [34], although studies have also demonstrated no statistical
significance between outcomes in children with or without Down syndrome and
Hirschsprung's disease [35, 36]. Results in all studies should however be viewed with
caution due to the small sample sizes. Further population based research is needed
regarding congenital gastrointestinal disorders by children with Down syndrome and the
outcomes and ongoing implications of the disorders for the children, families, and the
health care system.

Respiratory problems

Respiratory conditions including pneumonia, bronchitis and obstructive sleep apnoea are
considered a major cause of morbidity for children with Down syndrome. Respiratory
infections are the leading cause for hospital admissions among children with Down
syndrome beyond the neonatal period, especially for those with congenital heart disease
[37] and are shown to be a major cause of death [3]. However, due to the varied means of
data attainment, discrepancies in the literature exist as to whether respiratory or cardiac
defects contribute most to mortality in children with Down syndrome.

Obstructive sleep apnoea, which involves complete or partial upper airway obstruction
during sleep, is reported to occur in approximately 60% of children with Down syndrome
[38, 39]. The higher prevalence of this condition can be attributed to common
physiological and anatomical characteristics observed in children with Down syndrome
including midface hypoplasia, large adenoids or tonsils, narrow nasoorophaynx and
eustachian tubes, systemic hypotonia [27] and inner ear dysplasia [40]. It is reported that
parents substantially underestimate the prevalence and severity of obstructive sleep
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apnoea assuming that irregular breathing during sleep is normal for children with Down
syndrome [38]. As obstructive sleep apnoea may be associated with lower IQ
performance [41] and behaviour

probl~:ns

[42], parents need to be informed of the

prevalence of sleep apnoea and its associated implications.

Ophthalmic defects

Ophthalmological problems are over represented in the Down syndrome population and
if not corrected can result in substantial secondary disability [26]. Common
ophthalmological disorders include refractive errors, strabismus, nystagmus and
congenital cataracts [43, 44]. Hyperopia and myopia occur in approximately 43% of
children with Down syndrome [44] and contribute to their fivefold increased likelihood
of wearing glasses compared to. their peers [29]. In addition, as children with Down
syndrome frequently present with poor accommodation [45], bifocal spectacles should be
considered for those who under-accommodate [46].

Strabismus, occurring in

approximately 42% of children with Down syndrome, also contributes to vision
impairment [47], and is positively associated with learning difficulties [48]. As sensory
defects contribute substantially to disability, vigilant monitoring is required for children
with Down syndrome to optimise opportunities for learning and development, and to
increase quality of life.
Ear and hearing defects

Children with Down syndrome have a high incidence of hearing impairment [28, 49].
Hearing loss is reported to be prevalent in over 50% of children with Down syndrome
[26] and is defined as conductive, sensorineural or mixed [28]. While conductive hearing
loss arises frequently in children with Down syndrome due to episodes of otitis media or
middle ear dysfunction, sensorineural hearing impairments become increasingly
prevalent with age [50]. It is recommended that children with Down syndrome undergo
regular audiological screening for early identification of hearing impairments to minimise
or correct hearing loss and reduce secondary speech problems [51].

Anatomical malformations, systemic hypotonia and an increased susceptibility to
infections result in a high incidence of otitis media among children with Down syndrome
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[52] and can lead to glue ear and transient conductive hearing loss. Although grommet
insertion is disproportionately higher among children with Down syndrome compared to
the general population [53], a systematic review concluded that this procedure is only
minimally effective in reversing this loss [54]. Conversely, results qf a longitudinal study
have suggested that aggressive evaluation and treatment of chronic otitis media
significantly improves hearing levels in children with Down syndrome [55]. Clearly more
research is needed to guide clinical interventions in this area.

Musculoskeletal problems

Approximately 20% of children with Down syndrome experience musculoskeletal
disorders [56] due to a predisposition to hypotonia, lax ligaments and skeletal dysplasias
[26]. Commonly occurring musculoskeletal conditions include: patellar instability,
metatarsus primus, pes planus (flat foot), scoliosis and atlantoaxial instability [57]. Minor
podiatric anomalies including pes planus, foot pronation and metatarsus primus, are often
neglected due to a greater focus on the more severe pathologies associated with Down
syndrome [58] . There is therefore a need to ensure early identification of minor
musculoskeletal impairments is provided to prevent subsequent biomechanical and
postural problems.
Atlantoaxial instability, reported to occur in approximately 10% to 20% of people with
Down syndrome [59], has been considered to be particularly dangerous due to the
potential risk of compression and damage to the spinal cord. Atlantoaxial instability is
primarily attributed to laxity of the transverse ligament which results in instability of the
spine at Cl-C2 [59], or as a result of hypoplasia or malformations of the odontoid [57].
Previously, fear of the potentially catastrophic consequences of atlantoaxial instability led
to recommendations for routine screening and the restriction of certain sporting activities
[26]. These recommendations have now been revised such that routine screening is
mainly indicated for children with Down syndrome who are symptomatic or who
participate in contact sports [60].
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Endocrine
Endocrine anomalies, especiallythyroid dysfunction [61] and diabetes [62], are reported
to be more common among people with Down syndrome than the general population.
Estimates of thyroid dysfunction among people with Down syndrome have varied from
approximately 8.5% [61] to 38% [63). These estimates vary in relation to population
characteristics (age, size, race), diagnostic criteria and variations in operational
definitions used in studies. Hypothyroidism can be congenital or acquired and has a
greater prevalence than hyperthyroidism with approximately 10% of school aged children
with Down syndrome having this condition [26). As the prevalence of hypothyroidism
increases with age, and is similar in its presentation to Down syndrome itself, early
annual biochemical screening has been previously recommended to identify thyroid
disease [60]. In America, rates of medically treated thyroid disease in people with Down
syndrome increased by 73% after the release of the American Academy of Pediatrics
Health Supervision Guidelines [64]. Although these rates are based on a study with
limited generalisability due to its sample selection, the benefits of increased physician
awareness and subsequent rates of screening can be seen. However, there is disagreement
)}

over the frequency of screening for thyroid dysfunction with some authors concluding
that annual screening in not justified within the first two decades of life [61].

Down syndrome is also associated with diabetes and is reported to have a prevalence rate
between 1.4 and 10.6% for Type 1 [65]. The increased prevalence for Type 1 diabetes
may be genetically linked to the mutation of chromosome 21 which may be associated
with the early onset and high frequency of autoimmune diseases [66]. As diabetes is
relatively common among people with Down syndrome in comparison to the general
population, further research should examine the substantial secondary health concerns
experienced by children with diabetes, and the increased carer responsibility regarding
monitoring of dietary requirements and medication management.

Leukaemia

Although the overall risk of cancer for people with Down syndrome is equal to the
general population, the risk of developing leukaemia is significantly higher [67, 68).
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Children with Down syndrome have a nineteen fold increased risk of developing
leukaemia than their normally developing peers [69, 70], with the

m~ority

of cases being

diagnosed before the age of five [68]. This increased risk is apparent in data from the
Western Australian Cancer Registry with 53% of all cancers recorded in people with
Down syndrome resulting from childhood leukaemia [3]. Although survival outcomes
following treatment for leukaemia for children with Down syndrome are similar to the
general population, treatment is often poorly tolerated [28]. This may be associated with
the high levels of comorbidity experienced by children with Down syndrome which
complicate treatment and management regimes.

Interestingly, people with Down syndrome in all age groups have a decreased risk of
solid tumours [67, 68, 71]. Possible reasons for this decrease may be related to reduced
exposure to environmental carcinogens or directly related to the tumour -suppressor
genes found on chromosome 21 [72]. It has been hypothesised that as people with Down
syndrome have three copies of the tumour-suppressor genes due to their extra
chromosome 21, their cells are less likely to lose all three functional copies of the
tumour-suppressor genes [72] which may therefore provide greater protection against
tumours.

General infections/viruses

Structural abnormalities and an immature immune system result in children with Down
syndrome being predisposed to recurrent infections and episodic illnesses. Commonly
occurring conditions include upper-respiratory infections [28, 73] and otitis media [28,
55]. Poorer immune functioning, leading to greater susceptibility to infection, is further
aggravated by frequent attendance at health care appointments, and comorbidity of
cardiac and pulmonary diseases [73].

A recent US population-based study demonstrated that children with Down syndrome
had a higher prevalence of ear infections, recent colds/flu, stomach illnesses and
diarrhoea than did children without Down syndrome [24]. A major contributor to this
increased susceptibility to illnesses is the array of immune dysfunctions affecting people
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with Down syndrome [74], including severely diminished expansion of T and B
lymphocytes [70]. Although the majority of the episodic illnesses common in children
with Down syndrome are not life threatening, their prevalent and recurrent nature may
add significantly to health care utilisation, increase the financial and emotional impact on
carers, and contribute to an overall decreased quality of life.

Discussion
As outlined, Down syndrome is associated with many co-morbid conditions, health
problems and an increased risk of mortality compared to the general population.
Improvements in the medical management of co-morbidities and surgical advances have
reduced morbidity among children with Down syndrome, however congenital cardiac
defects, along with respiratory problems are still considered a major cause of mortality
[3]. Children with Down syndrome are predisposed to an array of health conditions and
impairments, transcending the sensory, endocrine, musculoskeletal and haematological
systems. While the estimated prevalences for these conditions vary between studies, this
is likely the result of diverse sample characteristics, data collection methods, coding
terminologies and study methodologies (population-based versus clinical or hospital
based). Overall, it is evident that high levels of co-morbidity significantly impact on the
quality oflife for children with Down syndrome and their families.

Parents of children with Down syndrome may experience an emotional and financial
impact from the medical co-morbidities experienced by their child. Parents have reported
that their child's increased needs had diminished their finances to the extent that
recreational activities and material items were often unaffordable [75]. Having a child
with Down syndrome has also been associated with limited parental time for other
children, reduced family socialisation [75] and poor maternal health [76]. Parents
therefore need a clear understanding of the medical co-morbidities associated with Down
syndrome to assist in making informed decisions regarding possible terminations of
pregnancy or in making future plans for their child and family.
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Despite the widespread acknowledgement of the co-morbidities experienced by children
with Down syndrome and their health effect, limited literature is available on medical
utilisation and health expenditures. A Western Australian study [29] presented an
overview of service utilisation for children with Down syndrome. However, as the role of
the Disability Services Commission, which coordinated medical services for people with
an intellectual disability, has since changed, these data may no longer reflect the actual
service use of children with Down syndrome in Western Australia. For children under
five with Down syndrome, medical costs were 12 to 13 times higher than in the general
population [77]. Also, children under five with an intellectual disability were more likely
to be admitted to hospital and for longer periods of time than their peers [78]. However,
limited research has examined health service utilisation for children over five with Down
syndrome or how the need for medical care changes with age. This knowledge would
result in a better understanding of the service needs for this population and assist in
provision and resource allocation of disability and medical services.
This literature review has implications for screening and subsequent management of comorbidities. Many of the co-morbidities experienced by children with Down syndrome, if
left untreated, contribute to substantial secondary disability, resulting in unnecessary
hardship and further disadvantage. Sensory defects are a primary example. As vision and
hearing contribute to learning, language development and socialisation [48, 79, 80], the
lack of regular screening and subsequent management of impairments not only affects the
sensory systems involved but a child's chances of academic success and socialisation.
Furthermore, as some children with Down syndrome are reported to have a as few as one
reciprocal friend [81, 82], and experience limited peer interactions outside school [81],
the importance of minimising disability and limiting secondary disability is highlighted.
Guidelines for the screening of medical conditions associated with Down syndrome have
been published [27, 51, 60]. However, to what extent these are actually being
implemented within schools and the health care system remains unknown. Further
research is needed to provide an understanding of the current screening policies and
guidelines being implemented and their effectiveness in identifying all the health
conditions experienced by children with Down syndrome.
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Finally, this literature review has important implications for health care professionals and
education providers. A clear understanding of the co-morbidities experienced by children
with Down syndrome provides a base for health care providers to plan and deliver safe
and effective intervention programs suitable for each child's physical capacities and
limitations. Knowledge of medical conditions is also valuable to health care professionals
who are in a position to provide prospective parents with current information to facilitate
informed decision making and future plans. In addition, as teachers play a valuable role
in children's development, an understanding of the medical conditions and their
functional impact on children with Down syndrome may facilitate the implementation of
classroom strategies which minimise disability and foster academic achievement and
socialisation with peers.
This literature review has synthesised the most current and relevant literature relating to
the medical conditions experienced by children with Down syndrome, however its
limitations must be acknowledged. As this was not a systematic review the
methodological quality of the research was not formally evaluated. Instead, this narrative
literature review was undertaken to summarise findings and provide an overview of the
common medical conditions experienced by children with Down syndrome. Furthermore,
a meta-analysis was not performed due to the differences between cohorts (population,
school or hospital based cohorts) and the varied methods of collecting prevalence
estimates.

Conclusion
This review of the literature supports the conclusion that many children with Down
syndrome experience additional birth defects and health related problems which impact
on their quality of life. Medical conditions commonly associated with Down syndrome
include; cardiac and gastrointestinal disorders, musculoskeletal disorders, respiratory
problems, eye and visual defects, ear and hearing impairments, and frequent episodic
illnesses and infections. In addition, children with Down syndrome have an increased risk
of developing leukaemia and thyroid conditions. Although considerable research has
documented these conditions, there is limited research examining the impact of levels of
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co-morbidity on everyday functioning. Understanding the impact of high levels of comorbidity would lead to the development of more effective interventions for teachers and
health care professionals, and also assist in the provision and resource allocation of
disability services.
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Changes over time in medical conditions and service use by children
with Down syndrome

Background: Children with Down syndrome commonly experience a variety of medical
conditions and health care problems. Although vast improvements in the medical
management of these conditions has occurred, changes in the overall health status of
children with Down syndrome over time, is yet to be explored. Furthermore, research is
limited which examines service utilisation for children with Down syndrome or the
impact of socio-demographic factors on access to services.
Aim: To compare the prevalences of parent reported medical conditions, and use of
services, by school aged children with Down syndrome in Western Australia between
1997 and 2004. In addition this study aims to describe the impact of socio-demographic
factors on medical service utilisation in 2004.
Methods: This study involved the comparison of two cross sectional surveys completed
by parents of children with Down syndrome in 1997 and 2004. The surveys collected
information of family demographics, medical conditions, health issues and service
utilisation. Frequency distributions were used to describe medical conditions in 2004 and
formal tests of association were based on chi-square tests. Regression analyses were used
to compare medical conditions and service use between the 1997 and 2004 cohorts.
Results: Children with Down syndrome in 2004 had significantly greater odds of having
a bowel condition than children in 1997 (OR 1.68, 95% CI 1.16 - 2.45). In 2004 children
had approximately 50% less likelihood of having a current problem due to their cardiac
condition (OR 0.52, 95% CI 0.28-1.00). An overall reduction in the incidence rates of
episodic illnesses and infections was seen in 2004. The use of GP services (IRR=0.91,
95% CI 0.83, -1.00) and combined medical specialist visits (IRR=0.92, 95% CI 0.841.01) were reduced in 2004. Overnight hospital admissions (IRR 0.60, 95% CI 0.37 0.96) and length of stay (IRR 0.33 95% CI 0.24- 0.44) were also reduced in 2004.
Conclusion: The health status of children with Down syndrome has varied over time.
Most importantly, children in 2004 experienced a significant reduction in current cardiac
problems and episodic illnesses that may contribute to improvements in overall health
and impact quality of life. In addition, children with Down syndrome are using less
medical services in 2004. These findings have implications for parents, health
professionals and in the provision and resource allocation of disability services in
Western Australia.

Author: Kelly Thomas
Supervisors: Dr Sonya Girdler,
Dr Helen Leonard and Ms Jenny Bourke
Submission date: September, 2009
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Changes over time in medical conditions and service use by children
with Down syndrome

Introduction
Down syndrome is a chromosomal birth disorder and the single most common cause of
intellectual disability [1 ], affecting 1 per 1000 births. It is well documented that Down
syndrome is strongly correlated with maternal age

[2]. Major demographic shifts in

westernised societies have resulted in increasing maternal age due to the changing roles
of women leading to the postponement of pregnancy. As a result, the number of overall
Down syndrome pregnancies has increased [2]. However, with the greater utilisation and
accessibility of antenatal screening programs [4], and increases in terminations of
pregnancies [5], the prevalence of Down syndrome births has remained relatively stable.
Children with Down syndrome experience an array of medical conditions and health care
problems which have been widely documented. There is a predisposition for children
with Down syndrome to develop medical co-morbidities [6] which may present ongoing
health issues and contribute to an increased risk of developing recurrent episodic illness
and infections. However, improvements in the medical management of these conditions
has lead to increased rates of infant and child survival and decreased morbidity [7]. These
medical improvements include, surgical advances and management of congenital heart
defects [8], improved accessibility to antibiotics and vaccinations, and changes in
community and health professionals' attitudes towards the treatment methods for people
with Down syndrome [9]. With these improvements in health management, it is expected
that further improvements in the health of children with Down syndrome will be seen
over time.

Although data are limited, there is a growing body of research which suggests that
children with Down syndrome have higher rates of health utilisation than their peers [1012]. However, to our knowledge, no literature has examined changes in service utilisation
over time, especially within the Down syndrome population. Furthermore, since 2002,
Western Australia has seen changes in the provision of disability medical specialist
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services with these services no longer being provided by the Disability Services
Commission (DSC). As a result the service utilisation of children with Down syndrome,
and how these have changed over time, is currently unknown. Furthermore, the impact of
socio-demographic factors on accessibility of medical services for children with Down
syndrome is also unexplored. As families of children with an intellectual disability are
shown to be more frequently economically disadvantaged [13], it is reasonable to assume
that inequalities exist in access and utilisation of specialist medical services which are not
fully government subsidised. An understanding of the socio-demographic disparities
which exist for families of children with Down syndrome is important for effective policy
development and equality in resource allocation.

Although the benefits of improved medical management have been described in terms of
survival [8,14], limited literature has examined the reduction of co-morbidities, or the
general health and frequency of illnesses in children with Down syndrome over time.
With the improvements of medical care, and more effective treatments early in life, it is
expected in this study that children with Down syndrome would experience less episodic
illnesses and ongoing problems associated with their medical conditions over time.
Furthermore, we predicted that with these reductions in illnesses and ongoing problems
due to medical conditions, coupled with the restructuring of the specialist services out
into the community, a decline in service utilisation may be evident. Finally, we aim to
describe the impact of socio-demographic factors on medical service utilisation and
examine whether they impacted on specialist medical services which are not fully
government subsidised.

Methodology
Methods

This study involved the comparison of two cross sectional surveys conducted in 1997 and
2004 using a Western Australian population data source of children with Down
syndrome. Figure 1 illustrates the study process.

In 1997 cases were principally

ascertained directly through the Disability Services Commission (DSC), a government
body coordinating medical and therapy services in Western Australia for people with an
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intellectual disability. Families with a child with Down syndrome born between 1980 and
1991, living in Western Australia were identified and mailed a questionnaire. The total
response fraction obtained was 79.5% (n = 210/264).
In 2004 a second survey was conducted with cases identified through the Intellectual

Disability Exploring Answers (IDEA) database, a population data source which uses
multiple sources of ascertainment including the Disability Services Commission and the
Department of Education and Training [15]. Five hundred families, with a child with
Down syndrome were aged 25 years and younger and registered with the Disability
Service Commission, were invited to participate in the study. In 2004, the total response
fraction was 73% (n = 363/500). The present analysis restricted data to subjects who were
school aged in 2004 (n=208) to ensure a comparable age sample to the 1997 cohort.

Instruments
The 1997 and 2004 ·questionnaires sent to families of children with Down syndrome
obtained similar information on family demographic characteristics, medical conditions
and health related conditions experienced by their child. Questions relating to medical
conditions asked if the child with Down syndrome had ever had a certain medical
condition, and if so, was the condition considered a current problem or requiring ongoing
medical treatment. In addition, the questionnaire gathered information on health service
utilisation including type and frequency of health care professional visits over the
previous 12 months. Both questionnaires were pilot tested to ensure their capacity to
elicit relevant and important information.

Data coding and management
In coding the data children were categorised into three age groups (5-9 years; 10-13

years; 14-17 years). Socio-demographic predictors used in data analysis for the 2004
cohort included parental education, father's occupational skill level, maternal work
status, family income and place of residence (See Table I). Participants' postcodes were
used to categorise place of residence. Father's occupational skill level was based on the
Australian and New Zealand Standard Classification of Occupations [16], however
categories were recoded so that the lowest skill level would become the baseline. Data
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was entered into FileMaker Pro version 8.0, and variables consistently categorised across
the two cohorts. Data were then exported into STATA version 10 and the 1997 and 2004
data were linked for statistical analysis by matching on DSC record numbers.

Ethics approval for the 1996 study was granted by the Ethics Committee at Princess
Margaret Hospital for Children, and by the Disability Services Commission. Ethical
approval for the 2004 study was obtained through the Ethics Committee of the Women's
and Children's Health Services in Western Australia. Approval to link the two data sets
was obtained directly from the Disability Services Commission. Ethical approval for the
current study was granted by the Edith Cowan Human Research Ethics Committee.

Data analysis

The prevalences of medical conditions in 2004 were described as frequency distributions.
Formal tests of association between medical conditions and child characteristic factors of
age or gender, were based on chi-square tests. P-values below 0.05 were considered
statistically significant, however the clinical meaning of differences in variables was also
considered. The 2004 medical services, hospital admissions and episodic illnesses data
were annualised in order to provide an estimate comparable to the 1997 data. Logistic
regression was used to compare the prevalence of medical conditions between 1997 and
2004, and Poisson regression to compare rates of episodic illnesses and medical service
use. Two outliers where the respondents had clearly misinterpreted the question about
the use of medical services were excluded. To account for overlap of children within the
1997 and 2004 cohorts, regression analyses were conducted within a generalised
estimating equation framework [1]. Analysis of the impact of socio-demographic factors
on service use in 2004 involved multivariate regression models. Hospitalisation rates for
the general population for school aged 5-17 years in 1997 and 2004 were accessed [18],
and incidence rate ratios calculated in order to make comparisons between the general
population and children with Down syndrome.
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Results
Sample characteristics
The sample characteristics of the 1997 cohort have previously been described in detail
[19]. Table I outlines the socio-demographic characteristics of families in 2004. The
mean age ofthe 2004 study subjects was 11.7 years (range 5.02 -17.98) and there were
90 females and 118 males. All children whose parents responded 202/202 (100%) lived
in their family home and 135/149 (90.6%) lived with both parents. Mothers provided the
majority of day-to-day care needs in 200/208 (96.2%) cases.

Medical conditions

Medical conditions in the 2004 cohort
Specific medical conditions in school aged children with Down syndrome in the 1997
cohort have been previously described [19]. The medical conditions in the 2004 cohort
are shown in Table II. Cardiac conditions were present in 95 (55.7%) children, with the
most common cardiac conditions being ventricular septal defects (N=33, 16%) and atrial
septal defects 25 (12% ). Congenital bowel conditions were reported in 66 (31. 7%)
children, with duodenal atresia occurring in 9 (4.3%) cases, while constipation was
present in 20% (N=41) of children with Down syndrome. Over half of the children were
reported to have had an ear condition 123 (59.1%). Glue ear occurred most frequently
(86, 41.3%) while hearing loss was reported in 36 (17.3%) children. Over two thirds of
children presented with visual defects (140, 67.3%), the most frequent ofthese were short
sightedness (52, 25%) and strabismus (45, 21.6%), while parents of 45 (21.6%) children
reported their child was long sighted. Twenty-six (12.5%) parents reported their child to
have had a thyroid disorder, with hypothyroidism occurring in 22 (22.6%) of children and
hyperthyroidism reported in three (1.4%) children. No statistically significant differences
were apparent across age groups or gender for all these medical conditions.
Seventy-four (35.6%) children were reported to have ever had a musculoskeletal
condition. Flat feet occurred most frequently (N= 47, 22.6%) and were more common
among girls (X2 =6.6, P= 0.01). Twenty-eight (59.6%) of these children wore orthotics

Medical Conditions in Down Syndrome 33

and use was again higher among females (X 2 =5.65, P=0.02). Fifty eight (27.9%) children
had had X-rays of the cervical spine and in 4.3% (N=9) a diagnosis of atlantoaxial
instability had been made. Forty-eight (65%) parents reported that their child currently
experienced a problem associated with their musculoskeletal condition and this was most
commonly flatfeet (29/48, 60.4%).
Two thirds (126/208, 60%) of children had ever had a respiratory condition. Nearly 20%
of children were reported to have sleep apnoea and 42 (20.2%) had asthma. No
association was found between respiratory conditions and gender, however sleep apnoea
was more.prevalent in the 10-19 year old age group (x2= 7.89, P=0.02). Only 15% of
parents reported that their child had current or continued respiratory problems and no
statistically significant difference was apparent across age groups (x2 = 3.92, P=0.14).
Medical conditions in 2004 compared with 1997.
Table III outlines the likelihood of medical conditions and episodic illnesses in children
with Down syndrome in 2004 compared with 1997, including if they have ever had the
medical condition, and if they experience current problems associated with the condition.
School-aged children with Down syndrome in 2004 had greater odds (OR 1.68; 95% CI
1.16 - 2.45) of having any bowel condition than children in 1997 even after adjusting for
age (OR 1.69; 95% CI 1.13 - 2.52), and gender (OR 1.65; 95% CI 1.13 - 2.37).
Specifically, children in 2004 had higher odds of having a congenital bowel condition,
mainly duodenal atresia (OR 1.17; 95% CI 0.60- 2.28) as well as constipation (OR 1.20;
95% CI 0.77- 1.86). In 2004, children had a slightly higher likelihood of ever having a
cardiac (OR 1.11; 95% CI 0.90 - 1.39), ear (OR 1.13; OR 0.18 - 1.56) or thyroid
condition (OR 1.08; 95% CI 0.69 =- 1.70), and hearing loss had a 13% increased
likelihood (OR 1.13; 95% CI 0.68- 1.90). In 2004 there was a reduced prevalence of
overall eye conditions (OR 0.79; 95% CI 0.55 - 1.15), however long sightedness was
increased (OR 1.54; 95% CI 1.03 - 2.31) as was the likelihood of wearing glasses (OR
1.18; 95% CI 0.83- 1.66).
Children in 2004 had approximately 50% less likelihood of having a current problem due
to their cardiac condition (OR 0.52; 95% CI 0.28-1.00) which was further reduced when
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adjusting for age and gender (OR 0.32; 95% CI 0.15 - 0.68). In 2004, there was an
increased likelihood of bowel (OR 1.29; 95% CI 0.77 - 2.18), ear (OR 1.06; 95% CI
0. 74- 1.53) and thyroid (OR 1.54; 95% CI 0.89 - 2.66) conditions causing a current
problem or requiring ongoing treatment, while eye conditions showed a reduction (OR
0.84; 95% CI 0.60 -1.18)

An overall reduction in the incidence rates of episodic illnesses and infections among
children with Down syndrome was found in 2004 compared to 1997. The greatest
reductions were seen for episodes of tonsillitis (IRR 0.56; 95% CI 0.38-0.83) and ear
infections (IRR 0.77; 95% CI 0.62- 0.95).
Medical service use

Table IV illustrates the rate of service use in 2004 compared to 1997. The use of a
general practitioner (GP) (IRR 0.91; 95% CI 0.83 -1.00) and the combined medical
specialist visits (IRR 0.92; 95% CI 0.84- 1.01) showed a slight rate reduction in 2004.
There was also a reduction in disability specialist services (IRR 0.25; 95% CI 0.15- 0.41)
and audiologist use (IRR 0.80; 95% CI 0.61 - 1.04), but an increase for ear, nose and
throat (ENT) (IRR 1.12; 95% CI 0.89- 6.88), podiatry (IRR 0.67; 95% CI 0.50- 0.91)
and 'other' specialists (IRR 1.29; 95% CI 0.97- 1.72). Cardiologists were unable to be
compared over the two years due small numbers in cardiologist attendance.
Overnight hospital admissions (IRR 0.60, 95% CI 0.24- 0.44) and the total nights spent
in hospital (IRR 0.33 95% CI 0.24- 0.44) both showed marked decreased incidence rates
in 2004 compared with 1997. This paralleled, but was reduced further than the general
population of Western Australian school-age children for these two years (OR 0.88, 95%
CI 0.86 - 0.90). With respiratory conditions (IRR 0.28, 95% CI 0.09 - 0.90), there was
the greatest reduction in hospital admissions in 2004 with the average nights in hospital
decreasing from approximately five in 1997 to 1.6 nights in 2004. However there was an
increased rate of day hospital admissions (IRR 1.20, 95% CI 0.81 - 1. 76) in 2004 and in
both years these were commonly associated with dental procedures. This increase
paralleled the increase seen in the general population (OR 1.33 95% CI 1.29 - 1.36).
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The frequency of surgical interventions was reported in 1997 and 2004. The odds of
having cardiac and ENT surgery were comparable across years (OR 1.08; 95% CI 0.881.32) and (OR 1.01; 95% CI 0.74 - 1.38), respectively. However, in 2004 there was a
reduced likelihood of children having had eye surgery (OR 0.92; 95% CI 0.58 - 1.46),
and a 70% increase in the likelihood ofbowel surgery (OR 1.71; 95% CI 0.83- 3.52).

Impact of socio-demographic factors on service use in 2004
Table V outlines the effects of socio-demographic factors on service use for children with
Down syndrome. After adjusting for fathers' occupational skill level, family income,
maternal work status and place of residence, the rates of GP service use were three times
higher for children whose fathers were well educated (IRR 3.33; 95% CI 2.52- 4.41). All
fathers' skill levels above the baseline showed reductions in service use and children had
a comparable rate of GP service use for rural and metropolitan areas (IRR 1.00; 95% CI
0.81- 1.24).

After adjusting for the other socio-demographic factors, higher paternal education was
associated with increased specialist service use (IRR 1.63; 95% CI 1.30- 2.05). Children,
whose family's annual income ranged from $20 000 - $31 999, or $32 000- $51 999,
demonstrated the highest rates of service use, and had the strongest effect size within
income. Father's skill level had an opposite effect, with the lowest skill level (the
baseline) showing the highest rates of specialist service use.

Working mothers were

associated with reduced use of services (IRR 0.85; 95% CI 0.72 - 0.99) and little
difference was found between children living in rural or metropolitan areas (IRR 1.05;
. 95% CI 0.88- 1.27).

Within the model for overnight hospital admissions, none of the socio-demographic
indicators had statistically significant effects, except for father's occupational skill level
ofthree (IRR; 0.15, 95% CI 0.028- 0.83) and four (IRR; 0.28; 95% CI 0.08- 0.99) which
both demonstrated a reduction in overnight hospital admissions. Hospital day admissions
however, demonstrated a strong association between higher maternal education and
increased service use (IRR; 5.15, 95% CI 1.71 - 15.55). Significantly reduced hospital
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day admissions were seen for fathers who had an occupational skill level of one (IRR
0.23; 95% CI 0.08 - 0.63), three (IRR 0.30; 95% CI 0.12- 0.81) and four (IRR 0.28;
95% CI 0.12- 0.66) compared with the baseline which was the lowest skill level. Family
income showed no statistically significant associated with hospital day admissions.

Discussion
This study aimed to compare the prevalences of medical conditions and episodic illness
in 1997 and 2004 to see if an improvement in the health of children with Down syndrome
has occurred over time. In addition, this study compared the use of medical services
between these years in order to assess if the improved health of children with Down
syndrome, or the disbandment of specialist services at the Disability Services
Commission, has led to decreases in service use. Furthermore, the impact of sociodemographic factors on service use was described. The results of this study found a
significant reduction in ongoing cardiac conditions, while bowel and thyroid conditions
proved to be associated with increased ongoing problems in the later cohort. Eye
conditions showed a 20% reduction, while hearing loss had increased by 13% in 2004. Of
importance, was that episodic illnesses reported to have an overall reduction in 2004
indicating the improved health and reduction in illnesses not genetically encoded in
children with Down syndrome. Service use paralleled these results, showing a reduction
in both GP and specialist appointments, while overnight hospital admissions were also
significantly reduced. Higher paternal education appeared to have the strongest
relationship to increased service use in the majority of analyses, and socio-demographic
factors had the strongest impact on specialist and GP service use.
The most important finding in this study was the 50% reduction in parent reported current
cardiac problems in 2004 compared with 1997. It is therefore likely that this later cohort
may have benefited considerably from the recent improvements in early surgery and as a
result have less ongoing comorbidity associated with their heart lesions compared with
the earlier cohort. Several studies highlight the changing survival profile of children with
Down syndrome [8,14,19] which attribute increased survival mainly to advances in
cardiac surgery and the improved medical management of these conditions. As a result,
children with Down syndrome are able to experience not only improved survival, but a
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significant decline in the ongoing cardiac comorbidities which pose a health risk for
children with Down syndrome and affect quality of life.
In 2004, children were reported to have an overall reduction in the number of episodic
illnesses and infections. These results would be in line with the improved cardiac status
we observed in 2004 as ongoing cardiac conditions often contribute to secondary
illnesses [20]. The improved health of children with Down syndrome can also be
attributed to greater access to, and effectiveness of, antibiotic treatments and vaccinations
within the health care system [9]. In the later cohort, ear infections especially were found
to have the highest rate of reduction. Given the similar rate ofENT surgery in both years
and the increased use of ENT specialists in 2004, the results indicate a trend towards
increased preventative health care which focuses on medical treatment other than surgical
intervention. The reduction in episodic illnesses was also reflected in the use of GP
services which saw a significant reduction in 2004. Our study is unique as it would
appear to be the first to have used population data to address rates of illnesses and
infections and service use, in children with Down syndrome over time. However, given
the reductions seen in episodic illnesses and infections, our study would support the
thesis that the health of children with Down syndrome has improved in recent years.
Hearing impairments in children with Down syndrome are well documented [21,22]. In
2004, a 13% increase in the number of Western Australian school-aged children with
hearing loss was found compared with 1997. As hearing is vital to language development
[23], and therefore contributes to learning and socialisation, regular screening and
subsequent management of impairments is vital in facilitating chances of academic
success and socialisation for children with Down syndrome. With the statistically
significant reduction in the use of audiologist services, and the increase of hearing loss
seen in the later cohort, our findings show some support for children with Down
syndrome to undergo regular screening for early identification of hearing impairments
[24] in order to minimise disability and limit secondary disability.
In 2004 parents reported higher rates of ongoing problems or the requirement of
continued treatment for thyroid and bowel conditions. For thyroid conditions, this might
be expected as once hypothyroidism is diagnosed, treatment is ongoing [25].
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Furthermore, greater awareness and the possible recognition and identification of thyroid
disease

[26] in later years may also account for some of the increase in thyroid

conditions requiring treatment. In 2004, despite the apparent increase in bowel
conditions, the ongoing associated problems were actually lower than what would be
expected. Given the increases in bowel surgery in the later cohort, the ongoing problems
may be the result of continued constipation. Although parents report thyroid and bowel
conditions as a current problem, they are most likely attributable to the necessity of
continued treatment rather than the cause of a current medical condition.
A high percentage (60%) of respiratory conditions was reported by parents in 2004. As
respiratory infections are considered a leading cause for hospital admissions among
children with Down syndrome [27] and are shown to be a major cause of mortality [28],
this may be cause for concern. However, parental report showed low prevalences in
current respiratory problems, and illnesses such as pneumonia and bronchitis were also
reduced. Furthermore, respiratory conditions represented the greatest reduction in
overnight hospital admissions and length of stay in 2004. These results demonstrate a
possible improvement in the frequency and severity of respiratory conditions in schoolaged children with Down syndrome. Sleep apnoea was reported to occur in 20% of
children with Down syndrome in the 2004 cohort. These prevalences were lower than
other studies [29,30]. This may be due to the smaller sample sizes than in the present
study, or that parents are reported to substantially underestimate the prevalence of sleep
apnoea assuming that irregular breathing during sleep is normal for children with Down
syndrome . As sleep apnoea may be associated with lower IQ performance [31] ,and
behaviour problems [32] parents need to be informed of the prevalence of sleep apnoea
and its associated implications.

In 2004, musculoskeletal conditions, the majority of which were 'flat feet', occurred in

35.6% of children with Down syndrome. 'Flat feet' is the most common musculoskeletal
condition reported for children with Down syndrome [33] and is temporarily correctable
with orthotics, worn by over half of the children with .flatfeet in our study sample.
Although only a minor musculoskeletal impairment, early identification and correction
should be provided to children with Down syndrome to prevent subsequent
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biomechanical and postural problems [33]. However, a reduction in podiatry services
were reported in 2004 indicating that children may no longer be receiving the level of
specialist services they require. Atlantoaxial instability was diagnosed in 4.3% of
children by cervical spine x-ray. These results are comparably lower than previous
studies [34,35] However, these studies are relatively dated, and since their publication
recommendations for routine screening for atlantoaxial instability have been revised such
that routine screening is currently only indicated for children with Down syndrome who
are symptomatic [36].
As previously mentioned, the use in GP services and combined specialist services were
decreased in 2004 compared with the earlier cohort. Given the phasing out of specialist
disability medical services at the Disability Services Commission in 2002, this trend is to
be expected as specialist services may no longer be as accessible to families. Specialist
services previously coordinated by the Disability Services Commission, for example
audiologists, have shown reductions in service use, yet the conditions managed by these
health professionals have increased, indicating the possibility that specialists services
may not be as accessible to this population as they once were in 1997. With regards to
the reduction in GP services, the general improvements in health of children with Down
syndrome are likely to influence the frequency of GP service attendance.

These

reductions in GP service use, are a positive indicator that the general health of children
with Down syndrome is improving.

In 2004 school-aged children with Down syndrome were reported to have increased day
admissions to hospital, while overnight hospital admissions were significantly reduced
compared with 1997. Interestingly, these trends in hospitalisations mirror that of the
general population of school-aged children.

However, young children with Down

syndrome demonstrated a greater decrease in overnight hospital admissions compared
with the general population, which may be indicative of improvements in health for
children with Down syndrome.

The impact of socio-demographic factors on service use were outlined in this study and in
places, showed an interesting contrast. Overnight hospital admissions and specialist
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services use demonstrated divergent trends. While many socio-demographic factors
impact on specialist services, few factors impact on overnight hospital admissions. The
limited association of socio-demographic factors on overnight hospital admissions may
demonstrate that overnight hospital admissions are not dependent on the socio-economic
gradient and are equitable for all children. This contrasts with the findings relating to
specialist service use which is greatly impacted on by socio-demographic factors. These
results may provide an insight into the level of accessibility in specialist service use for
families in Western Australia with a child with Down syndrome. However, some results
presented were difficult to explain. For example, higher paternal education was
associated with increased GP and specialist service use, while the lowest skill level for
fathers also demonstrated increased rates of service use. Little explanation can be offered
with regards to these findings, except that perhaps biases existed in the reporting of
parents. Future research would be beneficial which analyses the impact of sociodemographic factors on service use for children with Down syndrome based on
government Medicare data. This would also provide a comparison between parental
report and government data to understand biases which may exist in parental reporting.

In interpreting the findings of this study several limitations should be acknowledged. As
the data collection was based on a questionnaire, random recall error may have occurred
whereby parents inaccurately recorded answers due to memory recall over time. In cases
where there was missing data, results may be affected. Finally, the varied responses given
by parents due to the differing terminology they may have used could have lead to
possible encoding errors. However, although these limitations exist, this study provides a
valuable insight into the changing health of children with Down syndrome and their
service needs. To our knowledge, no other studies have described the changing health of
children with Down syndrome over time. Furthermore, although limited research has
described the increased medical service utilisation for children with Down syndrome
[10-12], our study is unique in providing an insight into the changes in medical service
use over time, and the impact" socio-demographic factors may have on service use, which
until now have been unexplored.
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The information provided in this study has important implications for parents, health care
professionals and education providers. A clear understanding of the co-morbidities
experience by children with Down syndrome and the knowledge that a reduction in
ongoing cardiac problems and improved health has occurred over time, will assist parents
in making informed decisions regarding future plans or possible terminations of
pregnancy. This information is also valuable to health care professionals in providing
effective programs and interventions suitable for each child's physical capacities and
limitations which minimise disability and facilitate development, functioning and
increase quality of life for children with Down syndrome. Finally, this research
contributes to the knowledge of medical service utilisation by this population and may
assist in the planning and provision of disability services in Western Australia.
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Figure 1: The study process
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Table I: Demographic characteristics of families in 2004
Characteristics

Families, N(%)
within each category

Parental Education
High maternal education (post
high school qualifications)
Low maternal education
(secondary education)
High paternal education

44/200 (22.0)

Low paternal education

156/200 (78.0)

62/202 (30.7)
140/202 (69.3)

Fathers occupational skill level
0 (Lowest skill level)

15/170 (8.8)

1

28/170 (16.5)

2

34/170 (20.0)

3

29/170 (16.1)

4 (Highest skill level)

64/170 (37.6)

Maternal work status
Working

97/195 (49.75)

Not working

98/195 (50.25)

Family income
Below $20,000

34/208 (16.4)

$20,000- $31,999

20/208 (9.6)

$32,000-$51,999

37/208 (17.8)

$ 52,000-$77,999

34/208 (16.4)

$78,000 onwards

44/208 (21.1)

Missing data

39/208 (18.8)

Place of Residence
Rural

164 (78.8)

Metropolitan

44 (21.2)
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Table II: Specific medical conditions in children with Down syndrome in 2004.
Condition

Children reported
to have the
condition N (%)

Cardiac: any

95 (45.7)
33 (15.9)
25 (12.0)
16(7.7)
11 (5.3)
8 (3.9)
2 (1.0)
66 (31.7)
41 (19.7)
9 (4.3)
0 (0.0)
0 (0.0)
123 (59.1)
86(41.3)
18 (8.7)
36 (17.3)
140 (67.3)
52 (25.0)
45 (21.6)
49 (23.6)
18 (8.6)

Ventricular septal defect
Atrial septal defect
A ventricular septal defect
'Hole in the heart'
Patent ductus arteriosis
Tetralogy ofFallot

Bowel: any
Constipation
Duodenal atresia
Coeliac disease
Hirschsprung disease

Ear or bearing: any
Glue ear
Perforated ear drum
Hearing loss

Eye or visual: any
Short sightedness
Long sightedness
Strabismus
Astigmatism
Nystagmus
Cataracts

Respiratory

9 (4.3)
6 (2.9)
26 (12.5)
22 (22.6)
3 (1.4)
74 (35.6)
9 (4.33)
47 (22.6)
5 (2.4)
3 (1.44)
126 (60.0)

Sleep apnoea
Asthma

39 (19.8)
42 (20.2)

Thyroid disease: any
Hypothyroidism
Hyperthyroidism

Musculoskeletal
Atlantoaxial instability
Flat feet
Scoliosis
Perthes
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Table III: Medical conditions and episodic illnesses in school aged children with
Down syndrome in 2004 compared with 1997.

Medical
condition:
ever
Current
problem
associated
with medical
condition
Frequency of
episodic
illnesses

Condition
Cardiac
Bowel
Ear
Eye
Thyroid
Cardiac
Bowel
Ear
Eye
Thyroid
Episodic illness
Cold or flu
Tonsillitis
Pneumonia
Bronchitis
Ear infection

Odds Ratio
1.11
1.68
1.13
0.79
1.08
0.52
1.29
1.06
0.84
1.54
IRR
0.92
0.56
0.90
0.80
0.77

95%
0.90
1.16
0.81
0.55
0.69
0.28
0.77
0.74
0.60
0.89
95%
0.81
0.38
0.31
0.52
0.62

Conf Interval
1.39
2.45
1.56
1.15
1.70
1.00
2.18
1.53
1.18
2.66
Conf Interval
1.04
0.83
2.57
1.23
0.95

Pvalue
0.32
0.01
0.47
0.23
0.73
0.05
0.33
0.73
0.31
0.12
Pvalue
0.19
<0.001
0.84
0.32
0.01
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Table IV: The use of medical services in 2004 compared with 1997.
Service

IRR

95% Conf. Interval

Pvalue

GP service visits
Specialist services combined
Paediatrician
Cardiologist
ENT specialist
Disability specialist
Eye specialist
Audiologist
Podiatrist
Dentist
Hospitalisations
Day admissions
Overnight admissions
Nights in hospital per
admission

0.91
0.92
0.96

0.83 1.00
0.84 1.01
0.72 1.28

0.05
0.09
0.77

1.12
0.11
0.97
0.80
0.67
1.13
IRR
1.20
0.60
0.33

-0.89
0.05
0.76
0.61
0.50
0.96

95%
0.81
0.37
0.24

1.42
0.22
1.22
1.04
0.91
1.33
Conf. Interval
1.76
0.96
0.44

0.34
<0.001
0.77
0.09
0.01
0.14

Pvalue
0.37
0.03
<0.001
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Table V: The effects ofsocio-demographic factors on service use for children with
Down syndrome in Western Australia in 2004.
GP service use

IRR

High maternal education
High paternal education
Father's skill level 1
Father's skill level 2
Father's skill level 3
Father's skilllevel4
$20,000- $31,999
$32,000-$51,999
$ 52,000-$77,999
$78,000 onwards
Missing data
Metropolitan area
Working mothers
Specialist service use
High maternal education
High paternal education
Father's skilllevell
Father's skilllevel2
Father's skill level 3
Father's skilllevel4
$20,000- $31,999
$32,000- $51,999
$ 52,000-$77,999
$78,000 onwards
Missing data
Metropolitan area
Working mothers
Overnight hospital
admissions
High maternal education
High paternal education
Father's skill level 1
Father's skill level 2
Father's skill level 3
Father's skill level 4
$20,000- $31,999
$32,000-$51,999
$ 52,000-$77,999
$78,000 onwards
Missing data
Metropolitan area

Pvalue

1.09
3.33
0.21
0.14
0.30
0.16
0.88
0.86
1.13
0.93
2.48
1.00
0.62

95% conf. Interval
0.90 1.31
2.52 4.41
0.17 0.28
0.10 0.18
0.24 0.38
0.13 0.20
0.60 1.28
0.63 1.19
0.82 1.55
0.68 1.26
1.86 3.29
0.81 1.24
0.53 0.73

1.18
1.63
0.59
0.63
0.66
0.60
1.67
1.80
1.21
1.20
1.24
1.05
0.85

0.98
1.30
0.44
0.47
0.49
0.46
1.16
1.31
0.86
0.87
0.88
0.88
0.72

1.42
2.05
0.79
0.84
0.89
0.79
2.40
2.48
1.69
1.66
1.74
1.27
0.99

0.09
<0.001
<0.001
0.002
0.006
<0.001
0.006
<0.001
0.28
0.28
0.21
0.58
0.04

1.28
0.99
0.44
0.32
0.15
0.29
0.30
0.49
3.91
0.86
2.65
1.39

0.48
0.29
0.12
0.08
0.03
0.08
0.18
0.07
0.83
0.15
0.54
0.56

3.44
3.34
1.65
1.26
0.833
0.99
5.04
3.72
18.40
5.03
12.95
3.44

0.48
0.98
0.22
0.10
0.03
0.49
0.40
0.49
0.08
0.87
0.22
0.48

0.39
<0.001
<0.001
<0.001
<0.001
<0.001
0.50
0.38
0.45
0.64
<0.001
0.05
<0.001
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Working mothers
Hospital day admissions
High maternal education
High paternal education
Father's skill level 1
Father's skill level 2
Father's skill level 3
Father's skill level 4
$20,000- $31,999
$32,000- $51,999
$ 52,000-$77,999
$78,000 onwards
Missing data
Metropolitan area
Working mothers

0.76

0.34

1.69

0.50

5.15
1.90
0.23
0.49
0.30
0.28
1.68
2.15
1.14
0.66
1.04
0.96
0.60

1.71
0.83
0.08
0.21
0.11
0.12
0.51
0.72
0.34
0.19
0.31
0.47
0.33

15.6
4.38
0.63
1.17
0.81
0.66
5.50
6.44
3.84
2.31
3.44
1.95
1.09

0.004
0.13
0.004
0.12
0.02
0.004
0.39
0.17
0.83
0.52
0.95
0.91
0.09
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